Project description:BackgroundThe purpose of a conference abstract is to summarize the main points of a research-related report that will be presented at an academic conference. However, some conferences accept and publish abstracts without results, which is contrary to the basic idea of a conference abstract as a dissemination tool. A conference abstract without results included is called a "promissory abstract". This study aimed to analyze the frequency and characteristics of promissory conference abstracts, i.e. abstracts submitted without results, accepted at Cochrane Colloquia.MethodsWe analyzed 8297 conference abstracts accepted at 25 Cochrane Colloquia, organized in 1994-2020, which were publicly available on the website of the Cochrane Library. Two authors screened abstracts to identify promissory abstracts. We extracted characteristics of promissory abstracts.ResultsAmong abstracts accepted for Cochrane Colloquia, 8.7% were promissory; 475 (66%) were accepted as poster presentations, 241 (34%) as oral presentations and 1 as a workshop. The median number of authors in promissory abstracts was 4 (interquartile range: 3 to 6 authors). In 245 (34%) promissory abstracts, affiliations of authors were not reported. The authors were most commonly affiliated with the following countries: UK (472; 36%), Canada (N = 123; 26%), China (N = 76; 16%), United States (N = 66; 14%) and Australia (N = 53; 11%). There were 512 (71%) promissory abstracts in which study design was not reported.ConclusionPromissory abstracts were commonly accepted at Cochrane Colloquia. Such abstracts deserve further attention, as they are detrimental in terms of the dissemination of new knowledge presented at a conference. Conference organizers could ask authors to update the abstract results subsequently to enable the dissemination of information presented at a conference.
Project description:Scottish Event Campus, Glasgow, Sunday 4 - Tuesday 6 November 2018 Attendees of the 2018 NCRI Cancer Conference will be able to contact corresponding authors through the Conference App and e-poster platform at the Conference.W: https://conference.ncri.org.uk : E: conference@ncri.org.ukOrganised by the National Cancer Research Institute, which is a partnership of 19 cancer research funders, the NCRI Cancer Conference provides a platform for researchers, clinicians, people affected by cancer and industry representatives to come together to discuss, present and showcase high-quality research. Sponsorship Statement: Publication of this supplement was sponsored by Roche. All content was reviewed and approved by the NCRI Scientific Committee, which held full responsibility for the abstract selection.